Celltrion
068270.KS
#738
Rank
NZ$47.39 B
Marketcap
$220.24
Share price
0.44%
Change (1 day)
-23.09%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.92

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $5.34. In 2022 the company made an earnings per share (EPS) of $5.20 a decrease over its 2021 EPS that were of $6.18.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.92-5.44%
2022$5.20-15.84%
2021$6.1812.77%
2020$5.4870.79%
2019$3.2115.63%
2018$2.78-33.13%
2017$4.15141.17%
2016$1.728.28%
2015$1.5911.28%
2014$1.4316.37%
2013$1.23-67.42%
2012$3.7784.22%
2011$2.0562.13%
2010$1.2680.61%
2009$0.70-559.63%
2008-$0.15-123.16%
2007$0.66